Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
Junko Yabuuchi, Seiji Ueda, Sho‐ichi Yamagishi, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs
Aleksandra Twarda‐Clapa, A. Olczak, Aneta Białkowska, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1312-1312
Open Access | Times Cited: 366
The degree of frailty as a translational measure of health in aging
Susan E. Howlett, Andrew D. Rutenberg, Kenneth Rockwood
Nature Aging (2021) Vol. 1, Iss. 8, pp. 651-665
Closed Access | Times Cited: 201
Homeostasis in the Gut Microbiota in Chronic Kidney Disease
Shruti Bhargava, Erik Merckelbach, Heidi Noels, et al.
Toxins (2022) Vol. 14, Iss. 10, pp. 648-648
Open Access | Times Cited: 42
Advanced Glycation End-Products and Their Effects on Gut Health
Kate Phuong-Nguyen, B. A. McNeill, Kathryn Aston‐Mourney, et al.
Nutrients (2023) Vol. 15, Iss. 2, pp. 405-405
Open Access | Times Cited: 39
Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease
Elena Dozio, Lara Caldiroli, Paolo Molinari, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 584-584
Open Access | Times Cited: 23
Renal failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice
Naoyuki Kawao, Miku Kawaguchi, Takashi Ohira, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 1, pp. 758-771
Open Access | Times Cited: 28
Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight
Chia‐Ter Chao, Shih‐Hua Lin
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6270-6270
Open Access | Times Cited: 37
Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress
Elena Dozio, Simone Vettoretti, Giuseppe Lungarella, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 405-405
Open Access | Times Cited: 36
Sarcopenia and sarcopenic obesity in chronic kidney disease: update on prevalence, outcomes, risk factors and nutrition treatment
Maria Inês Barreto Silva, Kelly Picard, Márcia Regina Simas Torres Klein
Current Opinion in Clinical Nutrition & Metabolic Care (2022) Vol. 25, Iss. 6, pp. 371-377
Closed Access | Times Cited: 24
Formation mechanism of AGEs in Maillard reaction model systems containing ascorbic acid
Lichun Liu, Lei Liu, Jianhua Xie, et al.
Food Chemistry (2022) Vol. 378, pp. 132108-132108
Closed Access | Times Cited: 22
Muscle food and human health: A systematic review from the perspective of external and internal oxidation
Zhaoming Wang, Zhiyuan Wu, Juncai Tu, et al.
Trends in Food Science & Technology (2023) Vol. 138, pp. 85-99
Closed Access | Times Cited: 15
The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD
Niki L. Reynaert, Lowie E.G.W. Vanfleteren, Timothy N. Perkins
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3366-3366
Open Access | Times Cited: 14
Use of frailty assessment instruments in nephrology populations: a scoping review
Alice Kennard, Suzanne Rainsford, Nicholas Glasgow, et al.
BMC Geriatrics (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Interactive effects of intrinsic capacity and obesity on the KDIGO chronic kidney disease risk classification in older patients with type 2 diabetes mellitus
Weihua Tang, Teng‐Hung Yu, Hui-Lan Lee, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Frailty Is Associated with Malnutrition–Inflammation Syndrome in Older CKD Patients
Paolo Molinari, Lara Caldiroli, Matteo Abinti, et al.
Nutrients (2024) Vol. 16, Iss. 16, pp. 2626-2626
Open Access | Times Cited: 5
The role of AGEs in muscle ageing and sarcopenia
Zhao-jing Guo, Hengzhen Li, Shide Jiang, et al.
Bone and Joint Research (2025) Vol. 14, Iss. 3, pp. 185-198
Open Access
Fate of myofibrillar protein-bound Nε-(carboxymethyl)lysine in the presence of the human colonic microbiota after gastrointestinal digestion
Shuqi Hao, Zeyu Lu, Mengyu Ye, et al.
Food Bioscience (2025), pp. 106380-106380
Closed Access
Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease
Kensei Taguchi, Kei Fukami, Bertha C. Elias, et al.
Toxins (2021) Vol. 13, Iss. 5, pp. 361-361
Open Access | Times Cited: 27
Methylglyoxal Induces Inflammation, Metabolic Modulation and Oxidative Stress in Myoblast Cells
Sota Todoriki, Yui Hosoda, Tae Yamamoto, et al.
Toxins (2022) Vol. 14, Iss. 4, pp. 263-263
Open Access | Times Cited: 16
Nano-Technological Approaches for Targeting Kidney Diseases With Focus on Diabetic Nephropathy: Recent Progress, and Future Perspectives
Bo Lin, Ying‐Yu Ma, Wang Jun-wei
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 16
Comparison of intestinal absorption of soybean protein isolate-, glutenin- and peanut protein isolate-bound Nε-(carboxymethyl) lysine after in vitro gastrointestinal digestion
Shuqi Hao, Mengyu Ye, Na Li, et al.
Food Research International (2024) Vol. 192, pp. 114811-114811
Closed Access | Times Cited: 3
Subcutaneous Infusion of DNA-Aptamer Raised against Advanced Glycation End Products Prevents Loss of Skeletal Muscle Mass and Strength in Accelerated-Aging Mice
Yusaku Mori, Makoto Ohara, Michishige Terasaki, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3112-3112
Open Access | Times Cited: 7
Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics
Jiayuan He, Xiang Li, Man Yan, et al.
Journal of Diabetes Research (2024) Vol. 2024, pp. 1-14
Open Access | Times Cited: 2
The gut microbiome, chronic kidney disease, and sarcopenia
Guilang Zheng, Jingyuan Cao, Xiaonan H. Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
Paolo Molinari, Lara Caldiroli, Elena Dozio, et al.
Antioxidants (2021) Vol. 10, Iss. 12, pp. 1994-1994
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top